Vericel (VCEL) Cash & Equivalents (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.19% |
| Dec 31, 2025 | -0.31% |
| Sep 30, 2025 | 24.67% |
| Jun 30, 2025 | 9.58% |
| Mar 31, 2025 | -1.38% |
| Dec 31, 2024 | 38.82% |
| Sep 30, 2024 | 6.74% |
| Jun 30, 2024 | -20.09% |
| Mar 31, 2024 | -8.90% |
| Dec 31, 2023 | 14.25% |
| Sep 30, 2023 | 40.56% |
| Jun 30, 2023 | -30.42% |
| Mar 31, 2023 | 21.08% |
| Dec 31, 2022 | -21.70% |
| Sep 30, 2022 | 16.34% |
| Jun 30, 2022 | 0.71% |
| Mar 31, 2022 | -18.54% |
| Dec 31, 2021 | 25.25% |
| Sep 30, 2021 | 5.39% |
| Jun 30, 2021 | -10.99% |
| Mar 31, 2021 | 72.97% |
| Dec 31, 2020 | -22.73% |
| Sep 30, 2020 | -21.90% |
| Jun 30, 2020 | 22.10% |
| Mar 31, 2020 | 69.67% |
| Dec 31, 2019 | -27.13% |
| Sep 30, 2019 | 163.57% |
| Jun 30, 2019 | -60.10% |
| Mar 31, 2019 | 91.86% |
| Dec 31, 2018 | -65.69% |
| Sep 30, 2018 | -43.89% |
| Dec 31, 2014 | -19.25% |
| Sep 30, 2014 | 414.77% |
| Dec 31, 2013 | -25.49% |
| Sep 30, 2013 | 140.68% |
| Jun 30, 2013 | -51.29% |
| Mar 31, 2013 | -32.35% |
| Dec 31, 2012 | -35.33% |
| Sep 30, 2012 | -26.43% |
| Jun 30, 2012 | -21.96% |
| Mar 31, 2012 | 564.25% |
| Dec 31, 2011 | -53.71% |
| Sep 30, 2011 | -35.49% |
| Jun 30, 2011 | -24.78% |
| Mar 31, 2011 | -21.21% |
| Dec 31, 2010 | 116.01% |
| Sep 30, 2010 | 2.46% |